Mexidol® in memory of memory, anxiety, decreased mood, depression

Time codes:
  • 00:00

    Features of therapy for memory disorders in the elderly

  • 00:13

    The causes of memory disorders

  • 00:32

    Symptoms of memory disorders

  • 00:45

    How to choose the necessary drug?

Mkhitaryan Elen Araikovna – PhD, Associate Professor of the Department of Aging Diseases of the Faculty of Continuing Professional Education of the Russian National Research Medical University named after N.I. Pirogov of the Ministry of Health of the Russian Federation, Head of the Laboratory of Neurogeriatrics of the Russian Scientific Clinical Center

Announcement:

Memory impairment is a common problem among the elderly. These disorders are often associated with cerebrovascular accidents and associated medical conditions. Patients not only lose the ability to remember information but also experience anxiety, low mood, and other symptoms. In this video, we'll discuss the causes of memory impairment, how to choose the right medication for treatment, why Mexidol® for memory has a pronounced ability to improve memory, and how Mexidol® works for depression.

Block of articles on this topic

The effectiveness and safety of the drug Mexol Forte 250 in the framework of consecutive therapy in patients with chronic brain ischemia

Author:
E.I. CHUKANOVA, A.S. CHUKANOVA

Department of Neurology, Neurosurgery and Medical Genetics of Faculty of Faculty of Faculty of FSBEI in "RNIMU named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia

The connection of cellular aging, cardiovascular diseases and anxiety disorders

Author:
A.P. Pereverzev

FSBOU DPO RANMO of the Ministry of Health of Russia

The study of the effectiveness and safety of the use of Mexidol and Mexidol Forte 250 in patients with chronic brain ischemia

Author:
V.A. KUTASHOV, O.V. ULYANOVA

FSBEI in Voronezh State Medical University named after N.N. Burdenko »Ministry of Health of Russia, Voronezh, Russia

Features of pharmacotherapy of vascular cognitive impairment in elderly people

Author:
A.N. BOGOLEPOVA1,2

1N.I. Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation, Moscow, Russia;
2Federal Center for Brain and Neurotechnology of the Federal Medical and Biological Agency of Russia, Moscow, Russia

THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.

Source of photos and images Shutterstock.com